Essential elements of personalized medicine

Wylie Burke, Susan Brown Trinidad, Nancy Press

    Research output: Contribution to journalArticle

    19 Citations (Scopus)

    Abstract

    Objectives: Genomic information has been promoted as the basis for "personalized" health care. We considered the benefits provided by genomic testing in context of the concept of personalized medicine. Materials and Methods: We evaluated current and potential uses of genomic testing in health care, using prostate cancer as an example, and considered their implications for individualizing or otherwise improving health care. Results and Conclusions: Personalized medicine is most accurately seen as a comprehensive effort to tailor health care to the individual, spanning multiple dimensions. While genomic tests will offer many potential opportunities to improve the delivery of care, including the potential for genomic research to offer opportunities to improve prostate cancer screening and treatment, such advances do not in themselves constitute a paradigm shift in the delivery of health care. Rather, personalized medicine is based on a partnership between clinician and patient that utilizes shared decision making to determine the best health care options among the available choices, weighing the patient's personal values and preferences together with clinical findings. This approach is particularly important for difficult clinical decisions involving uncertainty and trade-offs, such as those involved in prostate cancer screening and management. The delivery of personalized medicine also requires adequate health care access and assurance that basic health needs have been met. Substantial research investment will be needed to identify how genomic tests can contribute to this effort.

    Original languageEnglish (US)
    Pages (from-to)193-197
    Number of pages5
    JournalUrologic Oncology: Seminars and Original Investigations
    Volume32
    Issue number2
    DOIs
    StatePublished - Feb 2014

    Fingerprint

    Precision Medicine
    Delivery of Health Care
    Prostatic Neoplasms
    Early Detection of Cancer
    Research
    Uncertainty
    Decision Making
    Health

    Keywords

    • Genetics
    • Genomics
    • Health technology assessment
    • Personalized medicine
    • Pharmacogenomics
    • Prostate cancer

    ASJC Scopus subject areas

    • Oncology
    • Urology

    Cite this

    Essential elements of personalized medicine. / Burke, Wylie; Brown Trinidad, Susan; Press, Nancy.

    In: Urologic Oncology: Seminars and Original Investigations, Vol. 32, No. 2, 02.2014, p. 193-197.

    Research output: Contribution to journalArticle

    Burke, Wylie ; Brown Trinidad, Susan ; Press, Nancy. / Essential elements of personalized medicine. In: Urologic Oncology: Seminars and Original Investigations. 2014 ; Vol. 32, No. 2. pp. 193-197.
    @article{20668df9ccdd4d9f8050f81c2a60fc16,
    title = "Essential elements of personalized medicine",
    abstract = "Objectives: Genomic information has been promoted as the basis for {"}personalized{"} health care. We considered the benefits provided by genomic testing in context of the concept of personalized medicine. Materials and Methods: We evaluated current and potential uses of genomic testing in health care, using prostate cancer as an example, and considered their implications for individualizing or otherwise improving health care. Results and Conclusions: Personalized medicine is most accurately seen as a comprehensive effort to tailor health care to the individual, spanning multiple dimensions. While genomic tests will offer many potential opportunities to improve the delivery of care, including the potential for genomic research to offer opportunities to improve prostate cancer screening and treatment, such advances do not in themselves constitute a paradigm shift in the delivery of health care. Rather, personalized medicine is based on a partnership between clinician and patient that utilizes shared decision making to determine the best health care options among the available choices, weighing the patient's personal values and preferences together with clinical findings. This approach is particularly important for difficult clinical decisions involving uncertainty and trade-offs, such as those involved in prostate cancer screening and management. The delivery of personalized medicine also requires adequate health care access and assurance that basic health needs have been met. Substantial research investment will be needed to identify how genomic tests can contribute to this effort.",
    keywords = "Genetics, Genomics, Health technology assessment, Personalized medicine, Pharmacogenomics, Prostate cancer",
    author = "Wylie Burke and {Brown Trinidad}, Susan and Nancy Press",
    year = "2014",
    month = "2",
    doi = "10.1016/j.urolonc.2013.09.002",
    language = "English (US)",
    volume = "32",
    pages = "193--197",
    journal = "Urologic Oncology: Seminars and Original Investigations",
    issn = "1078-1439",
    publisher = "Elsevier Inc.",
    number = "2",

    }

    TY - JOUR

    T1 - Essential elements of personalized medicine

    AU - Burke, Wylie

    AU - Brown Trinidad, Susan

    AU - Press, Nancy

    PY - 2014/2

    Y1 - 2014/2

    N2 - Objectives: Genomic information has been promoted as the basis for "personalized" health care. We considered the benefits provided by genomic testing in context of the concept of personalized medicine. Materials and Methods: We evaluated current and potential uses of genomic testing in health care, using prostate cancer as an example, and considered their implications for individualizing or otherwise improving health care. Results and Conclusions: Personalized medicine is most accurately seen as a comprehensive effort to tailor health care to the individual, spanning multiple dimensions. While genomic tests will offer many potential opportunities to improve the delivery of care, including the potential for genomic research to offer opportunities to improve prostate cancer screening and treatment, such advances do not in themselves constitute a paradigm shift in the delivery of health care. Rather, personalized medicine is based on a partnership between clinician and patient that utilizes shared decision making to determine the best health care options among the available choices, weighing the patient's personal values and preferences together with clinical findings. This approach is particularly important for difficult clinical decisions involving uncertainty and trade-offs, such as those involved in prostate cancer screening and management. The delivery of personalized medicine also requires adequate health care access and assurance that basic health needs have been met. Substantial research investment will be needed to identify how genomic tests can contribute to this effort.

    AB - Objectives: Genomic information has been promoted as the basis for "personalized" health care. We considered the benefits provided by genomic testing in context of the concept of personalized medicine. Materials and Methods: We evaluated current and potential uses of genomic testing in health care, using prostate cancer as an example, and considered their implications for individualizing or otherwise improving health care. Results and Conclusions: Personalized medicine is most accurately seen as a comprehensive effort to tailor health care to the individual, spanning multiple dimensions. While genomic tests will offer many potential opportunities to improve the delivery of care, including the potential for genomic research to offer opportunities to improve prostate cancer screening and treatment, such advances do not in themselves constitute a paradigm shift in the delivery of health care. Rather, personalized medicine is based on a partnership between clinician and patient that utilizes shared decision making to determine the best health care options among the available choices, weighing the patient's personal values and preferences together with clinical findings. This approach is particularly important for difficult clinical decisions involving uncertainty and trade-offs, such as those involved in prostate cancer screening and management. The delivery of personalized medicine also requires adequate health care access and assurance that basic health needs have been met. Substantial research investment will be needed to identify how genomic tests can contribute to this effort.

    KW - Genetics

    KW - Genomics

    KW - Health technology assessment

    KW - Personalized medicine

    KW - Pharmacogenomics

    KW - Prostate cancer

    UR - http://www.scopus.com/inward/record.url?scp=84892547340&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84892547340&partnerID=8YFLogxK

    U2 - 10.1016/j.urolonc.2013.09.002

    DO - 10.1016/j.urolonc.2013.09.002

    M3 - Article

    C2 - 24321254

    AN - SCOPUS:84892547340

    VL - 32

    SP - 193

    EP - 197

    JO - Urologic Oncology: Seminars and Original Investigations

    JF - Urologic Oncology: Seminars and Original Investigations

    SN - 1078-1439

    IS - 2

    ER -